| |
|
|
|
Clovis Oncology Inc  
|
|
5.99 0.05 (0.01%) |
02-26 16:00 |
|
Open: |
6 |
Pre close: |
5.94 |
Target:
|
10.58
|
|
High: |
6.18 |
Low: |
5.82 |
Resistance:
|
9.06
11.10
|
|
Volume: |
6,808,696 |
Market Cap: |
626M |
Support:
|
5.75
4.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.16
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
7.76 |
Signal(12,26,9): |
0.13 |
|
MA(100): |
5.79  |
Stochastic Oscillator |
%K(14,3):
|
5.48 |
|
MA(250): |
6.28 |
%D(3): |
5.54 |
|
Average Volume(K) |
3-Month: |
795344
|
52-Week |
High:
|
11.10 |
|
10-Days: |
928196 |
Low: |
3.62 |
|
RSI |
RSI(14):
|
39.06 |
Change(%): |
-17.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.010 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
103.43 |
|
EPS Est. Current Year |
-7.580 |
Return on Assets (ttm) |
-31.4 |
Shares Float (M) |
80.68 |
|
EPS Est. Next Year |
-2.460 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.08 |
|
EPS Est. Next Quarter |
-1.150 |
Qtrly Rev. Growth |
3.1 |
% Held by Institutions |
60.69 |
|
Forward EPS |
-7.430 |
Gross Profit (p.s.) |
1.093 |
Shares Short (K) |
36120 |
|
Book Value (p.s.) |
-1.850 |
EBITDA (p.s.) |
-3.100 |
P/E |
-1.20 |
|
Sales Per Share |
1.552 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.24 |
|
Profit Margin |
-230.33 |
Operating Cash Flow
(M) |
-266.82 |
P/S |
3.86 |
|
Operating Margin |
-204.86 |
Levered Free Cash Flow
(M) |
-130.38 |
P/CF |
-2.32 |
|
|
|
|
|
|
